Home › NDC Lookup › RxCUI directory › RxCUI 707195

Acetaminophen 325 MG / guaifenesin 200 MG Oral Capsule — RxCUI 707195

RxNorm drug concept · Semantic clinical drug
RxCUI 707195 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 12 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI707195
Official nameAcetaminophen 325 MG / guaifenesin 200 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 325 MG / Guaifenesin 200 MG Oral Capsule
FDA products mapped11
Package NDCs mapped12
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
  • Why am I getting acetaminophen through an IV instead of just taking a pill?
  • Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
  • The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
📖 Read our full Acetaminophen Injection guide →

🕸️ Concept Web — How Acetaminophen 325 MG / guaifenesin 200 MG Oral C... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acetaminophen 325 MG / guaifenesin 200 MG Oral Capsule RxCUI 707195

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Acetaminophen 161
    • Guaifenesin 5032
    • Acetaminophen / guaifenesin 606096
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acetaminophen / guaifenesin Oral Capsule 707194
    • Acetaminophen / guaifenesin Oral Product 1151545
    • Acetaminophen / guaifenesin Pill 1151546
    • Oral Capsule 316965
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Acetaminophen 325 MG 315263
    • Guaifenesin 200 MG 317384
  4. Packs 1

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 12 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

📦 FDA Products & Package NDCs

11 products · 12 package NDCs
12 package NDCs map to RxCUI 707195 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
11523-0094-01 2 BLISTER PACK in 1 CARTON (11523-0094-1) / 12 CAPSULE, GEL... Coricidin HBP Maximum Strength Cold Flu And Chest Congestion Bayer HealthCare LLC. 2022-05-02
11523-0100-01 1 KIT in 1 BLISTER PACK (11523-0100-1) * 2 CAPSULE, LIQUID... Coricidin HBP Maximum Strength Cold and Flu Day and Night Bayer HealthCare LLC. 2022-07-01
51316-0940-16 2 BLISTER PACK in 1 CARTON (51316-940-16) / 8 CAPSULE, LIQU... Daytime CVS HEALTH CORP 2026-02-05
51316-0961-24 1 KIT in 1 CARTON (51316-961-24) * 4 CAPSULE, LIQUID FILLE... Daytime and Nighttime CVS HEALTH CORP 2026-04-01
72854-0136-16 2 BLISTER PACK in 1 CARTON (72854-136-16) / 8 CAPSULE, LIQU... Mucinex Cold and Flu Reckitt Benckiser LLC 2022-07-01
72854-0164-16 2 BLISTER PACK in 1 CARTON (72854-164-16) / 8 CAPSULE, LIQU... Mucinex Cold, Flu, and Sore Throat Reckitt Benckiser LLC 2025-06-01
72854-0211-08 1 BLISTER PACK in 1 CARTON (72854-211-08) / 8 CAPSULE, LIQU... Mucinex Sinus Max Clear and Cool RB Health (US) LLC 2025-06-01
72854-0211-16 1 BLISTER PACK in 1 CARTON (72854-211-16) / 16 CAPSULE, LIQ... Mucinex Sinus Max Clear and Cool RB Health (US) LLC 2025-06-01
72854-0212-02 1 CARTON in 1 CARTON (72854-212-02) / 1 KIT in 1 CARTON *... Mucinex Rapid Clear Pain, Headache, and Mucus Congestion and Sinus Max Clear and Cool Reckitt Benckiser LLC 2025-05-01
72854-0216-02 1 CARTON in 1 CARTON (72854-216-02) / 1 KIT in 1 CARTON *... Mucinex Rapid Clear Pain, Headache, and Mucus Congestion and Sinus Max Clear and Cool Reckitt Benckiser LLC 2025-05-01
72854-0217-24 2 BLISTER PACK in 1 CARTON (72854-217-24) / 1 KIT in 1 BLIS... MUCINEX Rapid Clear Pain, Headache and Mucus Congestion and Nighttime Liquid Gels RB Health (US) LLC 2025-06-01
83059-0052-01 1 BLISTER PACK in 1 CARTON (83059-0052-1) / 10 CAPSULE, LIQ... Maximum Strength Mucus Relief Plus Pain and Headache Shield Pharmaceuticals Corp 2026-05-06
Observed labelers: Reckitt Benckiser LLC (4) · RB Health (US) LLC (3) · Bayer HealthCare LLC. (2) · CVS HEALTH CORP (2) · Shield Pharmaceuticals Corp (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.